Sections

Home | Cancers | Breast Cancer

Breast Cancer

Exploring a New Approach to Treating Aggressive Breast Cancers

A new strategy for targeting a protein called GRP78 — overexpressed in many breast cancers — could be used to simultaneously provide ...

Biomarker could help guide cancer therapy, avoid drug resistance

Biologists link levels of Mena protein to breast cancer cells’ sensitivity to chemotherapy. ...

Most women unaware of breast density’s effect on cancer risk, UVA study finds

Most women don’t know that having dense breasts increases their risk for breast cancer and reduces a mammogram’s ability to detect cancer, according to a ... Full story

Drug combination therapy for estrogen-receptor–positive breast cancer passes critical step for worldwide approval

UCLA study showed positive results without the side effects of traditional chemotherapy ... Full story

Researchers Identify Protein Required for Breast Cancer Metastasis

Contact: Gina DiGravio, 617-638-8480, [email protected] (Boston)—Researchers have identified a new pathway and with it a protein, BRD4, necessary for breast cancer cells to spread. The findings, which ... Full story

Breast cancer patients have new surgery option with radioactive seed

UC Davis Comprehensive Cancer Center introduces new procedure ... Full story

Genetic Testing Could Help Identify Breast Cancer Patients at High Risk of Venous Thromboembolism

Older breast cancer patients with increased genetic susceptibility who received chemotherapy had the highest risk ... Full story

Silencing SIRT2, a sirtuin enzyme, reduces malignancy in deadly breast cancer subtype

New laboratory and animal study reveals underlying molecular mechanisms that drive malignancy and aggressiveness in basal-like breast cancer ... Full story

How does the gut microbiome influence breast cancer?

Researchers from the University of Illinois at Chicago and the University of Chicago have received a three-year, $900,000 Defense Department grant to investigate how the gut microbiome – the trillions of bacteria, viruses and other bugs that make our digestive systems their home – influences breast cancer. ... Full story

Cost-effectiveness of Herceptin for early stage breast cancer varies by age and tumour type

A new study from the University of Otago, Wellington (UOW) found that the cost-effectiveness of the drug trastuzumab (known more commonly as Herceptin®) in treating early stage breast cancer was highly variable depending on the disease characteristics and age of the woman. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 794 | displaying: 1 - 10